middle.news
BCAL Diagnostics Nears BREASTEST® Launch with Key Milestones and $7M Cash Buffer
10:00am on Friday 31st of January, 2025 AEDT
•
Healthcare
Read Story
BCAL Diagnostics Nears BREASTEST® Launch with Key Milestones and $7M Cash Buffer
10:00am on Friday 31st of January, 2025 AEDT
Key Points
BREASTEST® commercial launch planned for Q1 2025 at Sydney Breast Clinic
NATA accreditation achieved for BCAL's North Ryde laboratory
Australian patent accepted for BREASTEST® technology
Received $2.6 million R&D tax offset supporting development
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bcal Diagnostics (ASX:BDX)
OPEN ARTICLE